SPTN(SPTN)
SPTN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $9.84B | $10.01B | $10.21B |
| Low | $9.83B | $10.00B | $10.20B |
| High | $9.85B | $10.02B | $10.22B |
| EBITDA Avg | $122M | $124M | $126M |
| Low | $122M | $124M | $126M |
| High | $122M | $124M | $126M |
| EBIT Avg | $42M | $43M | $43M |
| Low | $42M | $43M | $43M |
| High | $42M | $43M | $43M |
| Net Income Avg | $60M | $57M | $58M |
| Low | $59M | $57M | $58M |
| High | $60M | $57M | $59M |
| EPS Avg | $1.74 | $1.66 | $1.71 |
| Low | $1.74 | $1.66 | $1.71 |
| High | $1.74 | $1.66 | $1.71 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $2.34B | $2.34B | $2.34B |
| Low | $2.34B | $2.34B | $2.34B |
| High | $2.34B | $2.34B | $2.34B |
| EBITDA Avg | $29M | $29M | $29M |
| Low | $29M | $29M | $29M |
| High | $29M | $29M | $29M |
| EBIT Avg | $10M | $10M | $10M |
| Low | $10M | $10M | $10M |
| High | $10M | $10M | $10M |
| Net Income Avg | $12M | $12M | $12M |
| Low | $12M | $12M | $12M |
| High | $12M | $12M | $12M |
| EPS Avg | $0.35 | $0.35 | $0.35 |
| Low | $0.35 | $0.35 | $0.35 |
| High | $0.35 | $0.35 | $0.35 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |